Halozyme Therapeutics shares owned by Vivaldi Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Vivaldi Capital Management
from 13F filings
Historical chart of Vivaldi Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Vivaldi Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Vivaldi Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.4M | 33k | 73.34 |
| 2025-06-30 | $1.8M | 35k | 52.02 |
| 2025-03-31 | $2.2M | 35k | 63.81 |
| 2024-12-31 | $2.0M | 35k | 55.86 |
| 2024-09-30 | $2.0M | 35k | 57.24 |
| 2024-06-30 | $1.8M | 35k | 52.36 |
| 2024-03-31 | $1.5M | 35k | 43.15 |
| 2023-12-31 | $1.2M | 35k | 34.64 |
| 2023-09-30 | $1.3M | 35k | 38.20 |
| 2023-06-30 | $1.3M | 35k | 36.07 |
| 2023-03-31 | $1.3M | 35k | 38.19 |
| 2022-12-31 | $1.9M | 35k | 55.04 |
More positions owned by Vivaldi Capital Management
View all positions for Vivaldi Capital Management